Cure8 research brief
Why This Matters
Better delineation of colitis‑associated neoplasia can improve the chance of complete endoscopic removal and help find residual disease that white‑light imaging may miss.
Who Should Pay Attention
Gastroenterologists/endoscopists, clinicians managing surveillance for ulcerative colitis, and patients undergoing dysplasia surveillance
Study Snapshot
What To Know
The paper is a four‑case report describing CV‑SCAN to highlight neoplastic areas not well seen with white‑light imaging. Targeted biopsy confirmed neoplasia, CV‑SCAN guided extent assessment, and ESD was used for resection.
Three cases had correspondence between CV‑positive areas and pathological extent with en bloc curative resection; one required a second ESD to remove residual disease that CV‑SCAN then identified. No procedure‑related adverse events or local recurrences were reported during follow‑up.
How to interpret: This is a small case series (four patients) reporting feasibility and potential utility of crystal violet staining as an adjunct to standard endoscopic imaging for delineating UC‑associated neoplasia prior to ESD.
It suggests CV‑SCAN may help detect residual neoplasia after initial resection, but larger studies are needed to confirm diagnostic accuracy and safety.
Keep In Mind
This is a four‑case report (abstract level provided). Findings are preliminary and based on a very small number of patients; the technique is described as an adjunct to—rather than a replacement for—standard imaging. Larger prospective studies would be needed to establish diagnostic performance and impact on outcomes.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.